Valuation: H.U. Group Holdings, Inc.

Capitalization 177B 1.11B 942M 870M 820M 1.52B 103B 1.55B 10.2B 4B 49.67B 4.16B 4.08B P/E ratio 2026 *
26.7x
P/E ratio 2027 * 27.5x
Enterprise value 200B 1.26B 1.07B 985M 928M 1.72B 117B 1.75B 11.54B 4.52B 56.22B 4.71B 4.61B EV / Sales 2026 *
0.8x
EV / Sales 2027 * 0.75x
Free-Float
98.83%
Yield 2026 *
3.93%
Yield 2027 * 3.93%
1 day-1.13%
1 week-1.93%
Current month-1.38%
1 month+1.52%
3 months-6.84%
6 months-15.11%
Current year-6.95%
1 week 3,077
Extreme 3077
3,212
1 month 2,944.5
Extreme 2944.5
3,327
Current year 2,944.5
Extreme 2944.5
3,578
1 year 2,623
Extreme 2623
4,093
3 years 2,167
Extreme 2167
4,093
5 years 2,167
Extreme 2167
4,093
10 years 2,005
Extreme 2005
5,570
Manager TitleAgeSince
Chief Executive Officer 72 01/06/2023
Director of Finance/CFO 55 23/06/2021
Chief Tech/Sci/R&D Officer 70 01/06/2021
Director TitleAgeSince
Director/Board Member 74 01/06/2014
Director/Board Member 55 01/06/2018
Chairman 72 01/06/2023
Change 5d. change 1-year change 3-years change Capi.($)
-1.13%-1.93%+19.29%+14.77% 1.11B
+4.51%+6.02%+38.20%+301.26% 27.79B
+0.15%+3.47%-18.74%-43.35% 7.27B
+1.27%+10.55%+23.10%+121.47% 4.66B
-0.62%-0.19%+3.32%+48.32% 2.53B
+3.13%+15.66%-27.77%+545.32% 1.92B
+0.84%+4.69%-2.83%-68.40% 1.86B
+0.55%-2.07%+34.83%+19.66% 1.86B
-0.31%+2.30%+39.82%-31.86% 1.72B
+0.33%+4.15%-1.74%+170.87% 1.13B
Average +0.90%+2.62%+10.75%+107.81% 5.19B
Weighted average by Cap. +2.67%-0.22%+21.90%+190.06%

Financials

2026 *2027 *
Net sales 249B 1.56B 1.33B 1.23B 1.16B 2.15B 146B 2.18B 14.38B 5.64B 70.05B 5.87B 5.75B 259B 1.62B 1.38B 1.27B 1.2B 2.23B 151B 2.27B 14.93B 5.85B 72.73B 6.1B 5.97B
Net income 6.71B 42.17M 35.81M 33.07M 31.17M 57.83M 3.92B 58.83M 388M 152M 1.89B 158M 155M 6.44B 40.47M 34.36M 31.73M 29.91M 55.49M 3.77B 56.45M 372M 146M 1.81B 152M 149M
Net Debt 23.3B 146M 124M 115M 108M 201M 13.62B 204M 1.35B 527M 6.55B 549M 538M 16.06B 101M 85.67M 79.1M 74.57M 138M 9.39B 141M 927M 363M 4.52B 378M 371M
Logo H.U. Group Holdings, Inc.
H.U. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The Company operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.
Employees
5,444
Date Price Change Volume
17/04/26 3,147.00 ¥ -1.13% 170,100
16/04/26 3,183.00 ¥ +0.54% 164,200
15/04/26 3,166.00 ¥ +1.05% 190,100
14/04/26 3,133.00 ¥ +0.22% 212,900
13/04/26 3,126.00 ¥ +0.13% 211,600
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
3,183.00JPY
Average target price
3,323.33JPY
Spread / Average Target
+4.41%

Quarterly revenue - Rate of surprise